Ownership and insider activity for PetMed Express, Inc. (PETS): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
PetMed Express, Inc., through its various subsidiaries, operates as a prominent pet pharmacy across the United States. The company provides a comprehensive range of both prescribed and over-the-counter animal medications, health-related items, and other essential supplies for canines, felines, and equines.
Price
| Price | $1.60 |
| Market Cap | $34M |
| Exchange | NASDAQ |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-08-11 | Campbell Leslie C.G. | A-Award | 60,000 | |
| 2026-08-11 | LaCamp James | A-Award | 55,555 | |
| 2026-08-11 | Batushansky Peter | A-Award | 55,555 | |
| 2026-08-11 | Mennen Justin L. | A-Award | 55,555 | |
| 2026-06-26 | KRULIK DOUGLAS | A-Award | 32,500 | |
| 2026-06-26 | KRULIK DOUGLAS | A-Award | 32,500 | |
| 2026-06-08 | NINA CAPITAL HOLDINGS INC. | P-Purchase | 25,000 | $44K |
| 2026-01-21 | FULGONI GIAN | D-Return | 26,057 | |
| 2025-10-30 | FULGONI GIAN | A-Award | 33,846 | |
| 2025-10-30 | KRULIK DOUGLAS | A-Award | 20,000 |
Balance Sheet (10y)
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $58.7M | $77.9M | $100.5M | $103.8M | $118.7M | $111.1M | $104.1M | $55.3M | $54.7M | $21.4M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | $1.8M | $2.3M | $2.5M | $3.8M | $2.6M | $1.9M | $1.7M | $3.3M | $2.3M | $1.9M |
| Inventory | $20.2M | $23.3M | $21.4M | $17.9M | $34.4M | $32.5M | $19.0M | $28.6M | $16.2M | $13.6M |
| Total Current Assets | $81.8M | $105.2M | $126.4M | $129.0M | $161.2M | $151.0M | $130.4M | $93.6M | $78.9M | $43.6M |
| Property, Plant & Equipment | $30.2M | $28.7M | $27.1M | $25.4M | $25.4M | $24.5M | $26.2M | $28.1M | $29.8M | $26.8M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $26.7M | $26.7M | 0 |
| Intangible Assets | $860000 | $860000 | $860000 | $860000 | $860000 | $860000 | $5.9M | $11.2M | $13.3M | $10.8M |
| Total Assets | $112.8M | $134.8M | $154.4M | $155.3M | $187.5M | $176.3M | $170.0M | $169.9M | $148.7M | $81.2M |
| Accounts Payable | $15.2M | $15.3M | $16.3M | $19.7M | $39.5M | $27.5M | $25.2M | $37.0M | $23.6M | $20.9M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $459000 | $461000 | $493000 |
| Total Current Liabilities | $18.4M | $18.1M | $18.6M | $24.3M | $44.9M | $33.2M | $57.5M | $72.2M | $62.8M | $52.0M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $535000 | 0 |
| Total Liabilities | $19.4M | $19.1M | $19.7M | $25.3M | $46.2M | $34.1M | $60.0M | $73.2M | $63.6M | $52.3M |
| Retained Earnings | $86.5M | $106.3M | $122.2M | $126.2M | $134.1M | $130.5M | $91.7M | $71.6M | $66.5M | $9.3M |
| Total Equity | $93.4M | $115.7M | $134.7M | $130.0M | $141.3M | $142.2M | $110.0M | $96.7M | $85.1M | $28.9M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | $995000 | $1.5M | $996000 | $535000 |
| Net Debt | -$58.7M | -$77.9M | -$100.5M | -$103.8M | -$118.7M | -$111.1M | -$103.1M | -$53.8M | -$53.7M | -$20.9M |
| Working Capital | $63.4M | $87.1M | $107.8M | $104.7M | $116.3M | $117.8M | $72.9M | $21.5M | $16.1M | -$8.5M |
Financial Health
| Debt / Equity | 0.02 |
| Current Ratio | 0.68 |
Profitability
| Return on Equity | -108.76% |
| Return on Invested Capital | -130.21% |
| Return on Assets | -45.92% |
| Gross Margin | 23.71% |
| Operating Margin | -18.22% |
| Net Margin | -17.34% |
Related companies: BDSX · CTSO · FBIO · GNTA · ICCM · MDAI · MDCX
Explore sector: Consumer Cyclical · Specialty Retail
More sections of PETS: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks